Want to join the conversation?
$SYK 1Q15 10-Q: Orthopaedics net sales rose 2.4%, primarily due to 9.6% growth in unit volume and product mix changes and 1% due to acquisitions. MedSurg rose 4.6%, primarily due to 3.9% growth in unit volume and product mix changes, 3.5% due to acquisitions and 0.4% due to changes in price. Neurotechnology and Spine net sales rose 2.1%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.